Are multivitamins worth it? What the trials show

Multivitamin pills spilled from a white bottle on a dark surface

Most multivitamins are not worth it. A minority are. Price does not predict which is which, and neither does ingredient count. What matters is whether the nutrients you are genuinely short of are in the tub, in a form you can absorb. The trial evidence sorts this out more clearly than the marketing does.

The short version

  • The USPSTF found evidence insufficient to recommend multivitamins against cancer or heart disease.
  • The COSMOS trials did show a real memory benefit in adults over 60.
  • 70% of Americans fall short on vitamin D, 45% on magnesium.
  • Absorption depends on form. Magnesium oxide absorbed at 4% in one trial.
  • Worth it depends on your own gaps, not the brand's marketing.

Where the expensive urine line comes from

The insult is older than most supplement brands. Water soluble vitamins that your body cannot store get filtered out by the kidneys, so if you take more than you need, you pay for the excess and then flush it. That part is true.

The stronger version of the argument comes from the US Preventive Services Task Force review published in JAMA in 2022. It concluded that the evidence is insufficient to determine whether multivitamins prevent cardiovascular disease or cancer in the general adult population. In the same statement the task force went further on two single nutrients, concluding with moderate certainty that the harms of beta carotene supplementation outweigh the benefits, and that vitamin E supplementation offers no net benefit for either outcome.

Read that carefully, because the industry misquotes it in both directions. Insufficient evidence is not proof that multivitamins do nothing. It means the trials have not settled the question. It does mean that if you are buying a multivitamin as insurance against cancer or a heart attack, you are buying something the data does not support.

What the research actually shows

Three findings are worth knowing, and none of them say what the adverts say.

The Physicians' Health Study II randomised 14,641 male US physicians aged 50 and over to a daily multivitamin or placebo and followed them for a median of 11.2 years. Men on the multivitamin had a statistically significant reduction in total cancer incidence, 17.0 against 18.3 events per 1,000 person years, a hazard ratio of 0.92. There was no effect on prostate cancer, on colorectal cancer, or on death from cancer. The benefit was real, small, and much narrower than the coverage suggested.

Cognition is where the evidence is stronger. In COSMOS-Web, 3,562 older adults took a daily multivitamin or placebo for three years. The multivitamin group scored better on immediate recall at one year and across the full three years. The authors estimated the effect was equivalent to about 3.1 years of age related memory change.

A 2024 meta-analysis pooling three COSMOS cognitive substudies found a benefit on global cognition of 0.07 standard deviation units, which the authors put at roughly two years less cognitive ageing.

Now the part most brands leave out. The supplement used in COSMOS was Centrum Silver, an ordinary supermarket multivitamin. The trial that produced the best evidence for multivitamins did not use a premium formula. Any brand citing COSMOS to justify a high price is citing a study that argues against its own pricing.

Whether yours is worth it depends on your gaps

A multivitamin can only help with a shortfall you actually have. So the useful question is which shortfalls are common.

An analysis of NHANES data covering 16,110 Americans looked at usual intakes from food, fortification and supplements combined, then compared them against the estimated average requirement. The proportion falling below it was 70% for vitamin D, 60% for vitamin E, 45% for magnesium, 38% for calcium, 34% for vitamin A and 25% for vitamin C. Only 3% of the population met the adequate intake for potassium.

Against that, the same analysis found only 8% falling short on vitamin B6, folate and zinc, and under 6% for thiamin, riboflavin, niacin, B12, iron, copper and selenium.

That is the whole argument in one paragraph. The nutrients most people are short of are vitamin D, magnesium and vitamin E. The nutrients most multivitamins shout about on the front of the tub are the B vitamins, which most people already get from fortified food. A product that piles on B vitamins and carries a token amount of magnesium is solving a problem you did not have.

Excess is real too. The same dataset found 10.3% of the population above the tolerable upper intake level for niacin and 8.4% above it for zinc. More stops helping once you pass the point of sufficiency.

Form and dose, where labels do the lying

Two products can list the same mineral at the same milligram figure and deliver very different amounts to your blood.

The clearest published example is magnesium. A bioavailability study of commercial magnesium preparations measured fractional absorption of magnesium oxide at 4%, against higher and roughly equivalent absorption from magnesium chloride, lactate and aspartate. Magnesium oxide is still the most common form in cheap multivitamins, because it is the cheapest way to put a large number on a label.

The second problem is disclosure. If a label shows a proprietary blend, the dose of each ingredient inside it is hidden, so you cannot check any of this for yourself. We covered what proprietary blends hide separately.

When a multivitamin is worth it, and when it is not

Worth it Not worth it
Your diet has a known gap, such as low vitamin D over winter You eat well and want cancer or heart disease insurance
The label states every ingredient, form and dose The dose sits hidden inside a proprietary blend
Minerals use absorbable forms rather than oxides Magnesium oxide is doing the heavy lifting
You are over 60 and care about memory You expect it to replace food and sleep
Doses sit between the requirement and the upper limit Doses run to several hundred percent of the requirement

What Fireblood does about it

Fireblood is built around the gap data rather than the label optics. Vitamin D3 at 50ug (2,000 IU) goes after the widest shortfall in that NHANES analysis, the one affecting 70% of people. Vitamin C at 500mg covers a much narrower gap, 25% below the requirement, and we are not going to inflate that. Magnesium is 100mg, supplied as D-magnesium malate and magnesium bisglycinate rather than oxide. Zinc is 11mg as zinc bisglycinate. Folate is 667ug DFE as L-5-methyltetrahydrofolate, and B12 is 2.5ug as methylcobalamin.

Two honest caveats. Magnesium at 100mg is a top up rather than a full day's requirement, and no daily powder carrying 39 ingredients could deliver a full magnesium dose without turning into a magnesium product. The vitamin E in the formula, 45mg of mixed tocopherols, is there because 60% of people fall below the requirement for it, not because it prevents anything. The task force was clear that vitamin E supplements offer no net benefit against cancer or cardiovascular disease, and we are not going to pretend otherwise.

The closing thought

Expensive urine is a fair description of a multivitamin that gives you more of what you already have. It is a poor description of one that closes a gap you genuinely have. So stop asking whether multivitamins work. Ask which shortfall yours is aimed at, and whether you have it.

Fireblood is a daily powder with 39 ingredients, every dose printed on the label, no proprietary blends. To see the full formula and check it against your own diet, the ingredient list is on the product page. We also broke down what a multivitamin should actually cost if you want the value side of this argument.